Search

Your search keyword '"Ruscheweyh, Ruth"' showing total 564 results
Start Over Author "Ruscheweyh, Ruth" Search Limiters Academic (Peer-Reviewed) Journals
564 results on '"Ruscheweyh, Ruth"'

12. Konsensusstatement der Migräne- und Kopfschmerzgesellschaften (DMKG, ÖKSG & SKG) zur Therapiedauer der medikamentösen Migräneprophylaxe

Author

Goßrau, Gudrun, Förderreuther, Stefanie, Ruscheweyh, Ruth, Ruschil, Victoria, Sprenger, Till, Lewis, David, Kamm, Katharina, Freilinger, Tobias, Neeb, Lars, Malzacher, Volker, Meier, Uwe, Gehring, Klaus, Kraya, Torsten, Dresler, Thomas, Schankin, Christoph J., Gantenbein, Andreas R., Brössner, Gregor, Zebenholzer, Karin, Diener, Hans-Christoph, Gaul, Charly, and Jürgens, Tim P.

Published
2023
Full Text
View/download PDF

18. Long COVID headache

Author

Tana, Claudio, Bentivegna, Enrico, Cho, Soo-Jin, Harriott, Andrea M., García-Azorín, David, Labastida-Ramirez, Alejandro, Ornello, Raffaele, Raffaelli, Bianca, Beltrán, Eloísa Rubio, Ruscheweyh, Ruth, and Martelletti, Paolo

Published
2022
Full Text
View/download PDF

21. Erratum zu: Konsensusstatement der Migräne- und Kopfschmerzgesellschaften (DMKG, ÖKSG & SKG) zur Therapiedauer der medikamentösen Migräneprophylaxe

Author

Goßrau, Gudrun, Förderreuther, Stefanie, Ruscheweyh, Ruth, Ruschil, Victoria, Sprenger, Till, Lewis, David, Kamm, Katharina, Freilinger, Tobias, Neeb, Lars, Malzacher, Volker, Meier, Uwe, Gehring, Klaus, Kraya, Torsten, Dresler, Thomas, Schankin, Christoph J., Gantenbein, Andreas R., Brössner, Gregor, Zebenholzer, Karin, Diener, Hans-Christoph, Gaul, Charly, and Jürgens, Tim P.

Published
2023
Full Text
View/download PDF

22. Pain Sensitivity Questionnaire: Cross‐cultural adaptation and validation of the Greek version.

Author

Bilika, Paraskevi, Aivatzidis, Ioannis, Kaloudis, Konstantinos, Gkotzamanis, Rafail, Ruscheweyh, Ruth, and Kapreli, Eleni

Abstract

Introduction: The Pain Sensitivity Questionnaire (PSQ) was developed to assess general pain sensitivity. Objective: This study aimed to validate the Greek version of PSQ. Methods: The questionnaire was translated into Greek (PSQ‐GR) and piloted in a small sample of patients with chronic pain (n = 35). A total of 146 chronic pain patients and healthy volunteers completed the PSQ‐GR, the Pain Catastrophizing Scale (PCS), Hospital Anxiety and Depression Scale (HADS) and Central Sensitization Inventory (CSI). To evaluate the test‐retest reliability, 36 volunteers completed the PSQ‐GR twice over 7 ± 2 days. Results: Internal consistency was excellent (Cronbach's alpha 0.90–0.96) for PSQ‐total, PSQ‐minor, and PSQ‐moderate. The Intraclass Correlation Coefficient was estimated at 0.90–0.96 for PSQ‐total, PSQ‐minor and PSQ‐moderate and the SEM was 0.59–0.90 for PSQ‐total, PSQ‐minor and PSQ‐moderate approximately. The smallest detectable change was 0.48 for PSQ‐total, 0.47 for PSQ‐minor and 0.44 for PSQ‐moderate. Positive and significant correlations were observed between PSQ‐GR and HADS (r = 0.38, p < 0.01), PCS (r = 0.41, p < 0.01) and CSI (r = 0.30, p < 0.01). Statistically significant differences in PSQ‐GR scores were identified between the healthy volunteers and the chronic pain patients. Conclusion: The PSQ‐GR is a reliable and valid tool that can assess pain sensitivity in healthy individuals and chronic musculoskeletal pain patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients

Author

Ornello, Raffaele, Ahmed, Fayyaz, Negro, Andrea, Miscio, Anna Maria, Santoro, Antonio, Alpuente, Alicia, Russo, Antonio, Silvestro, Marcello, Cevoli, Sabina, Brunelli, Nicoletta, Vernieri, Fabrizio, Grazzi, Licia, Baraldi, Carlo, Guerzoni, Simona, Andreou, Anna P., Lambru, Giorgio, Kamm, Katharina, Ruscheweyh, Ruth, Russo, Marco, Torelli, Paola, Filatova, Elena, Latysheva, Nina, Gryglas-Dworak, Anna, Straburzyński, Marcin, Butera, Calogera, Colombo, Bruno, Filippi, Massimo, Pozo-Rosich, Patricia, Martelletti, Paolo, and Sacco, Simona

Published
2021
Full Text
View/download PDF

25. Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study

Author

Ornello, Raffaele, Ahmed, Fayyaz, Negro, Andrea, Miscio, Anna Maria, Santoro, Antonio, Alpuente, Alicia, Russo, Antonio, Silvestro, Marcello, Cevoli, Sabina, Brunelli, Nicoletta, Vernieri, Fabrizio, Grazzi, Licia, Baraldi, Carlo, Guerzoni, Simona, Andreou, Anna P., Lambru, Giorgio, Frattale, Ilaria, Kamm, Katharina, Ruscheweyh, Ruth, Russo, Marco, Torelli, Paola, Filatova, Elena, Latysheva, Nina, Gryglas-Dworak, Anna, Straburzynski, Marcin, Butera, Calogera, Colombo, Bruno, Filippi, Massimo, Pozo-Rosich, Patricia, Martelletti, Paolo, and Sacco, Simona

Published
2021
Full Text
View/download PDF

27. Minimal important difference of the Migraine Disability Assessment (MIDAS): Longitudinal data from the DMKG Headache Registry.

Author

Ruscheweyh, Ruth, Förderreuther, Stefanie, Freilinger, Tobias, Gaul, Charly, Goßrau, Gudrun, Jürgens, Tim Patrick, Kraya, Torsten, Neeb, Lars, Ruschil, Victoria, Scheidt, Jörg, and Dresler, Thomas

Subjects
*RECEIVER operating characteristic curves, *MIGRAINE, *CHEMICAL yield, *HEADACHE, *CLINICAL trials
Abstract

Background: The Migraine Disability Assessment (MIDAS) is widely used. However, there are limited data on how much a reduction in the MIDAS score indicates a change that matters to the patient. Methods: Data from the DMKG (i.e. German Migraine and Headache Society) Headache Registry were used to determine the minimal important difference (MID) of the MIDAS, using the Patient Global Impression of Change (PGIC) as anchor and applying average change and receiver operating characteristic curve methods. Results: In total, 1218 adult migraine patients (85.6% female, 40.2 ± 12.8 years, baseline MIDAS 44.2 ± 47.4, follow-up MIDAS 36.5 ± 45.3) were included. For patients with baseline MIDAS >20 (MIDAS grade IV, n = 757), different methods using PGIC "somewhat improved" as anchor yielded percent change MIDs of the MIDAS between −29.4% and −33.2%. For baseline MIDAS between 6 and 20 (grades II and III, n = 334), using PGIC "much improved" as anchor, difference change MIDs were between −3.5 and −4.5 points. Conclusions: Based on the above results, we estimated the MID of the MIDAS at −30% for patients with a baseline MIDAS >20, and at −4 points for those with a baseline MIDAS of 6–20, for a tertiary headache care population. Trial Registration: The DMKG Headache Registry is registered with the German Clinical Trials Register (DRKS 00021081). [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

37. No pain, still gain (of function): the relation between sensory profiles and the presence or absence of self-reported pain in a large multicenter cohort of patients with neuropathy

Author

Forstenpointner, Julia, Ruscheweyh, Ruth, Attal, Nadine, Baron, Ralf, Bouhassira, Didier, Enax-Krumova, Elena K., Finnerup, Nanna B., Freynhagen, Rainer, Gierthmühlen, Janne, Hansson, Per, Jensen, Troels S., Maier, Christoph, Rice, Andrew S.C., Segerdahl, Märta, Tölle, Thomas, Treede, Rolf-Detlef, and Vollert, Jan

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results